This May, the Patient Voice Initiative is diving deeper into the evidence used to determine the value of medicines and healthcare with three webinars for patient groups and patients.

Friday 14 May 10am-11am – Clinical trials and the patient voice

How do clinical trials influence the health treatments we can access and how can the patient voice add value to them? Presenters: Janelle Bowden (AccessCR and Research Gamechangers) and Rare Cancers Australia Followed by time for your questions.

Friday 21 May 10am-11 am – Uncertainty and the patient voice

What uncertainties arise from the evidence when valuing medicines (and other health treatments) for reimbursement in Australia and how can the patient voice add value? Presenters: Professor Andrew Wilson (PBAC Chair) and Nicole Millis (Rare Voices Australia CEO) Followed by time for your questions.

Friday 28 May 10am-11 am – Health economics and the patient voice

How is health economics used to determine the value of medicines (and other health treatments) for reimbursement in Australia and how can the patient voice add value? Presenters: Dr Richard de Abreu Lourenco (Associate Professor with the Centre for Health Economics Research and Evaluation, UTS) and Dr Sally Wortley (Consumer Evidence and Engagement Unit, Office of Health Technology Assessment, Dept of Health)Followed by time for your questions.

Registration is free thanks to our sponsors by Gold: Amgen, Bristol-Myers Squibb, Lilly, Janssen, MSD, Roche and Sanofi. Silver: AstraZeneca, Biogen, Medicines Australia, Pfizer, Takeda, Vertex, Vifor Pharma